March 3, 2014 09:36 UTC

Research and Markets: PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022 Research Report

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/t9tcht/pharmapoint) has announced the addition of the "PharmaPoint: Obesity - UK Drug Forecast and Market Analysis to 2022" report to their offering.

After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this growing pipeline of late-stage drugs, this market is expected to experience substantial growth over the next decade.

Although the prevalence of obesity in the UK is one of the highest among the EU countries, it is a severely underserved market, with Xenical and its generic being the sole therapies for chronic weight management. Due to the high cost of therapy, most patients have been taking generic orlistat. In the UK, overweight and obesity are traditionally treated with lifestyle modifications, such as dietary regulation and increased physical activity.

Scope

- Overview of Obesity including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the top drugs in the UK from 2012-2022.

- Analysis of the impact of key events as well the drivers and restraints affecting the UK Obesity market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.

- Stay ahead of the competition by understanding the changing competitive landscape for Obesity.

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.

- Make more informed business decisions from insightful and in-depth analysis of drug performance.

- Obtain sales forecast for drugs from 2012-2022 in the UK.

For more information visit http://www.researchandmarkets.com/research/t9tcht/pharmapoint

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Source: Research and Markets